Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > Nitric Oxide Nasal Spray
View:
Post by indaknownewfie on Jun 01, 2020 11:25am

Nitric Oxide Nasal Spray

https://www.ctvnews.ca/health/coronavirus/could-a-simple-gas-produced-by-our-bodies-be-used-to-treat-covid-19-canadian-trials-underway-1.4962611

Kaly is onto something and Sazman has three patents about Nitric Oxide 

US and International Patent https://www.uspto.gov Once on the page, go to Searching Full Text Patents since 1976 Click on search by Patent number There are three patents by Andrew Salzman and they were applied for by Radikal Therapeutics Inc. which is wholly owned by the Salzman Group
The first patent is the one with the most detail and if you scroll down through it, the examples are all for the pro-drug R-107 which physiologically converts in your body. To R-100
Patent# 9,604,932
The second patent is Patent# 9,522,903
The third patent is Patent# 9,102,659
Comment by Moonshiner592 on Jun 01, 2020 1:05pm
Looks good to me!! ... bound to be more news on the way.... go Kaly GO! 
Comment by CBDKings on Jun 01, 2020 1:10pm
Great pivot to this by KLY, an FDA approval or BARDA grant would send this to 0.05 plus +++
Comment by Whatsastockdad on Jun 01, 2020 1:29pm
hope you got a lazy boy and some popcorn :D
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities